A Congresswoman with a record of voting against cannabis is now investing in the industry. Medical patients in Virginia are lining up at dispensaries to get their hands on recently approved cannabis flower. And a Native American tribe in New York is taking matters into its own hands while the rest of the state slowly moves towards implementing cannabis sales.
Republican Rep. Virginia Foxx of North Carolina, who has historically supported anti-cannabis legislation, is likely the largest holder of cannabis stocks in Congress. According to a financial disclosure report, Foxx has made at least six investments in Altria, one of the largest tobacco companies in the world. In 2018 Altria bought a $1.8 billion stake in multi-national cannabis company Cronos Group, granting the tobacco firm significant influence in the cannabis industry. Some experts have labeled Foxx’s actions a conflict of interest.
Qualifying medical patients in Virginia can now purchase up to four ounces of cannabis flower a month to treat their conditions. Prior to the new rules, which took effect on Sept. 1, patients in the state were limited to the use of cannabis oils and tinctures, which are more concentrated and have generally been found to provide less relief than the herbal form of the plant. The move marks a huge milestone for Virginia residents, who first secured access to medical cannabis in 2017.
The Saint Regis Mohawk Tribe of upstate New York officially began accepting applications for cannabis retail licenses on Sept. 13, meaning the Native American territory will likely host the first cannabis retailers in the state. Although former Gov. Andrew Cuomo signed an adult-use legislation bill into law in March of this year, cannabis dispensaries are not expected to open in other parts of the state until sometime in 2022. Members of the tribe approved a resolution supporting adult-use legislation in 2019.
I would like to apply for a license please.
Hi Angela! Please give our customer service line a ring and one of our agents will be able to further assist you đ 1-833-663-7284
I would like the opportunity to apply for a job and ID license
I would like to apply I have three crushed disk in my back an blind in one eye would much rather try this than any pharmaceutical
Hi there! Please give our customer service line 1-833-663-7284 a call and one of our agents can further assist you đ
Looking to an edible that has the strains ( Harlequin, Northern Lights or OG Kush ) mentioned on this email for migraines??
Suddenly, the world of magic mushrooms is almost as complicated as that of learning about cannabis. Shrooms or âmagicâ mushrooms have gained traction as a hallucinogenic therapeutic application for several different mental health circumstances such as depression and migrainesâparticularly when microdosing. Itâs not just liberty caps anymore, folks. There are many different varieties and types…
As of now, 15 states have legalized adult use of med and rec, and when a state legalizes recreational use of cannabis, people tend to stop getting their mmj cards. But cannabis consumers who opt not to get a MMJ card are missing out on a bunch of benefits like paying lower costs, the ability…
Edibles are arguably one of the best means of recreational cannabis consumptionâyou get to eat a treat AND experience a long-lasting high. But itâs easy to end up dealing with some unwanted side effects due to the variability in the onset of these THC-packed goodies, which come in the form of brownies, cookies, gummies, chocolate,…
If you’re reading this, you are either a recreational cannabis veteran who has seen a handful of cannabis smokers passing out from puffing a joint and can’t seem to figure out why. Or, you are a newbie who wants to give recreational or medical cannabis a shot, and the burning question on your mind is,…
According to a new study published by the University of New Mexico (UNM) in the prestigious journal Frontiers in Pharmacology, researchers have unveiled a significant correlation between the sensation of “feeling high” and the relief of medical symptoms among cannabis patients. This landmark study probes uncharted territories, challenging pre-existing assumptions and opening new avenues for…
